Abbott Laboratories Profit Jumps As All Business Units Shine
NEW YORK (Reuters) - Abbott Laboratories said on Wednesday fourth-quarter earnings jumped 28 percent on demand for its prescription drugs, nutritional products and medical devices, including its new Xience stent used to prop open coronary arteries.